219 related articles for article (PubMed ID: 11888680)
1. Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cells.
Norfleet AM; Bergmann JS; Carney DH
Gen Pharmacol; 2000 Nov; 35(5):249-54. PubMed ID: 11888680
[TBL] [Abstract][Full Text] [Related]
2. Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.
Ryaby JT; Sheller MR; Levine BP; Bramlet DG; Ladd AL; Carney DH
J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():132-9. PubMed ID: 17079379
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of full-thickness wound healing in normal rats by the synthetic thrombin peptide, TP508.
Stiernberg J; Norfleet AM; Redin WR; Warner WS; Fritz RR; Carney DH
Wound Repair Regen; 2000; 8(3):204-15. PubMed ID: 10886811
[TBL] [Abstract][Full Text] [Related]
4. Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia.
Norfleet AM; Huang Y; Sower LE; Redin WR; Fritz RR; Carney DH
Wound Repair Regen; 2000; 8(6):517-29. PubMed ID: 11208179
[TBL] [Abstract][Full Text] [Related]
5. The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound-healing cascade in vivo.
Martins-Green M; Feugate JE
Cytokine; 1998 Jul; 10(7):522-35. PubMed ID: 9702416
[TBL] [Abstract][Full Text] [Related]
6. On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin.
Tsopanoglou NE; Papaconstantinou ME; Flordellis CS; Maragoudakis ME
Thromb Haemost; 2004 Oct; 92(4):846-57. PubMed ID: 15467917
[TBL] [Abstract][Full Text] [Related]
7. Radiomitigation and Tissue Repair Activity of Systemically Administered Therapeutic Peptide TP508 Is Enhanced by PEGylation.
McVicar SD; Rayavara K; Carney DH
AAPS J; 2017 May; 19(3):743-753. PubMed ID: 28097629
[TBL] [Abstract][Full Text] [Related]
8. Effects of thrombin and of the phospholipase C inhibitor, D609, on the vascularity of the chick chorioallantoic membrane.
Dimitropoulou C; Maragoudakis ME; Konerding MA
Gen Pharmacol; 2000 Nov; 35(5):241-7. PubMed ID: 11888679
[TBL] [Abstract][Full Text] [Related]
9. Engineered adipose tissue supplied by functional microvessels.
Borges J; Mueller MC; Padron NT; Tegtmeier F; Lang EM; Stark GB
Tissue Eng; 2003 Dec; 9(6):1263-70. PubMed ID: 14670114
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis assays in the chick CAM.
Storgard C; Mikolon D; Stupack DG
Methods Mol Biol; 2005; 294():123-36. PubMed ID: 15576910
[TBL] [Abstract][Full Text] [Related]
11. Fibrin-based biomaterials to deliver human growth factors.
Wong C; Inman E; Spaethe R; Helgerson S
Thromb Haemost; 2003 Mar; 89(3):573-82. PubMed ID: 12624643
[TBL] [Abstract][Full Text] [Related]
12. Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth.
Rhim TY; Park CS; Kim E; Kim SS
Biochem Biophys Res Commun; 1998 Nov; 252(2):513-6. PubMed ID: 9826562
[TBL] [Abstract][Full Text] [Related]
13. Thrombin peptide TP508 stimulates rapid nitric oxide production in human endothelial cells.
Olszewska-Pazdrak B; Hart-Vantassell A; Carney DH
J Vasc Res; 2010; 47(3):203-13. PubMed ID: 19893317
[TBL] [Abstract][Full Text] [Related]
14. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
Ribatti D; Nico B; Vacca A; Roncali L; Burri PH; Djonov V
Anat Rec; 2001 Dec; 264(4):317-24. PubMed ID: 11745087
[TBL] [Abstract][Full Text] [Related]
15. The non-proteolytically active thrombin peptide TP508 stimulates angiogenic sprouting.
Vartanian KB; Chen HY; Kennedy J; Beck SK; Ryaby JT; Wang H; Hoying JB
J Cell Physiol; 2006 Jan; 206(1):175-80. PubMed ID: 16021627
[TBL] [Abstract][Full Text] [Related]
16. Effect of thrombin peptide 508 (TP508) on bone healing during distraction osteogenesis in rabbit tibia.
Amir LR; Li G; Schoenmaker T; Everts V; Bronckers AL
Cell Tissue Res; 2007 Oct; 330(1):35-44. PubMed ID: 17636332
[TBL] [Abstract][Full Text] [Related]
17. Wound healing in aged animals--effects of locally applied transforming growth factor beta 2 in different model systems.
Cox DA; Kunz S; Cerletti N; McMaster GK; Burk RR
EXS; 1992; 61():287-95. PubMed ID: 1377545
[TBL] [Abstract][Full Text] [Related]
18. Osteocalcin is angiogenic in vivo.
Cantatore FP; Crivellato E; Nico B; Ribatti D
Cell Biol Int; 2005 Jul; 29(7):583-5. PubMed ID: 15979904
[TBL] [Abstract][Full Text] [Related]
19. [An experimental study of the effects of thrombin receptor activating peptide (TP508) on healing of ischemic wound and flap survival in rats].
Huang Y; Yang Z; Li A
Zhonghua Shao Shang Za Zhi; 2001 Dec; 17(6):339-41. PubMed ID: 11859609
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
